• Fausto Ciccacci, Andrea Manto, Lelio Morviducci, Fabiana Lanti, Noorjehan Majid, Mustafa Agy, Cacilda Massango, Stefano Orlando, Giovanni Guidotti, and Maria Cristina Marazzi.
• UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.
• Afr Health Sci. 2022 Dec 1; 22 (4): 127132127-132.

IntroductionWHO estimates 422 million cases of diabetes mellitus worldwide. Mozambique has the second-highest mortality related to DM in the African region.Objectives of the present study are to provide data about a DM care service in Mozambique and to evaluate early outcomes of treatment.MethodsThe new patients diagnosed with DM in a two-years period in a health centre in Maputo (Mozambique) were included in a retrospective cohort study. Fasting blood glucose (FBG), waist circumference (WC) and BMI were collected at baseline and after three months.Results188 patients were enrolled. Median BMI, WC and FBG at baseline were respectively 28 kg/m2(Inter Quartile Range [IQR]23.4-31.8), 98cm (IQR 87-105) and 209mg/dL (IQR 143-295). A non-pharmacological intervention was prescribed for six patients, while 182 patients received metformin 500 mg b.i.d. FBG was significantly reduced at control (226[±103.7]mg/dL vs 186[±93.2]mg/dL, p<0.000); however, glycemic control was reached in 74 patients (39.4%); not controlled patients changed regimen. Elderly patients had a higher glycemic control (adjusted Odds Ratio 2.50, 95% CI 1.11-5.06, p=0.002).ConclusionStrategies for early detection of scarce glycemic control are feasible in Mozambique and could lead to prompt regimen switch; an invasive therapeutic approach could be preferable in selected cases to achieve control.© 2022 Ciccacci F et al.

16 keywords...

hide…